Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2021 Results – Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET
Company Participants
Jessica Serra – Head, IR and ESG
Mark Foley – President and CEO
Toby Schilke – CFO
Dr. Abhay Joshi – COO and President, R&D and Product Operations
…
